Welcome to our dedicated page for My Size SEC filings (Ticker: MYSZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on My Size's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into My Size's regulatory disclosures and financial reporting.
My Size, Inc. is registering the resale of up to 26,019,229 shares of common stock held or to be acquired by Square Gate Capital Master Fund, LLC – Series 5, all tied to an equity line of credit facility. This includes 25,000,000 ELOC Shares, 269,229 Initial Commitment Shares and up to 750,000 True-Up Commitment Shares.
The Equity Purchase Agreement lets My Size, at its discretion, sell up to $10,000,000 of stock to Square Gate over 36 months, with purchase prices set at discounts to market VWAP. My Size will not receive proceeds from investors’ resale of these shares but may receive cash when it sells ELOC Shares to Square Gate, which it plans to use for working capital and general corporate purposes.
As of August 6, 2026, My Size had 5,394,778 shares outstanding and 250,000,000 authorized, implying up to 31,144,778 shares outstanding if all registered shares are issued. The company highlights substantial potential dilution, pressure on its $0.36 share price, constraints from a 4.99% Beneficial Ownership Limitation and a 19.99% Exchange Cap. It also discloses Nasdaq listing risks, including a proposed $5.0 million Market Value of Listed Securities requirement versus its approximately $2.1 million MVLS, and geopolitical risks tied to operating from Israel.
My Size, Inc. entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, LLC - Series 5, giving it the right, but not the obligation, to sell up to $10,000,000 of common stock over a 36‑month period ending no later than August 5, 2029. Sales are initiated at the company’s discretion via regular or intraday put notices, subject to conditions and a 4.99% beneficial ownership cap.
An Exchange Cap initially limits issuance to 1,024,597 shares, or 19.99% of shares outstanding on the execution date, unless stockholders approve more or the average sale price reaches at least $0.3706. My Size paid a $100,000 commitment fee in 269,229 shares, with possible true‑up shares. Purchase prices are set at 96.5% of the lowest VWAP for regular puts or 100% of the lowest trade during intraday periods. The company agreed to standstill, variable‑rate, and competing equity line restrictions that can limit other equity financings, while the investor agreed not to short or hedge the stock. My Size will file a Form S‑1 within 30 days to register resale of the commitment shares, and any proceeds from future share sales will be used for working capital and general corporate purposes.
My Size, Inc. reported the results of its 2026 annual stockholder meeting. A quorum of 2,023,301 shares of common stock was represented. Stockholders elected Class II directors Oron Branitzky and Guy Zimmerman, each receiving more than 1.07 million votes in favor, to serve three-year terms.
Stockholders approved the advisory vote on executive compensation with 968,586 votes For. They also granted the Board discretionary authority to implement one or more Reverse Stock Splits of the common stock at ratios from 1-for-2 up to 1-for-30, which may be effected by July 21, 2027, including the treatment of fractional shares. An amendment to authorize issuance of blank check preferred stock did not receive the required majority of outstanding shares and was not approved. Stockholders ratified the appointment of Somekh Chaikin as independent public accountant with 1,901,844 votes For for the fiscal year ending December 31, 2026.
My Size, Inc. has called an annual stockholder meeting for July 21, 2026 in Tel Aviv. Stockholders will vote on electing two Class II directors, an advisory approval of 2025 executive pay, and a significant capital structure change.
The board seeks discretionary authority to implement one or more reverse stock splits of the common stock at ratios between 1‑for‑2 and up to 1‑for‑30, to be completed by July 21, 2027, primarily to help regain and maintain Nasdaq’s $1.00 minimum bid requirement. The company also asks approval to amend its charter to authorize issuance of blank check preferred stock, giving the board broad flexibility to create new preferred series. Stockholders will additionally vote on ratifying Somekh Chaikin as independent public accountant for the year ending December 31, 2026.
My Size, Inc. is soliciting proxies for its Annual Meeting of Stockholders to be held on July 21, 2026 in Tel Aviv. The board asks shareholders to vote FOR election of two Class II directors, advisory approval of executive compensation, authorization for a 1-for-2 to 1-for-30 reverse stock split, authorization to issue blank check preferred stock, and ratification of Somekh Chaikin as auditors.
The proxy statement sets the record date as May 27, 2026, states 4,818,164 shares outstanding as of that date, and discloses ownership and compensation tables, committee compositions, and equity awards. The board recommends approval of all listed proposals.
MySize, Inc. reported strong top-line growth for the first quarter of 2026 while remaining unprofitable. Revenue rose 62% year-over-year to about $2.39 million, driven mainly by fashion e-commerce operations and the consolidation of Percentil.
Gross profit more than doubled to roughly $940 thousand, with gross margin improving to 39.3% from 28.4%, reflecting better profitability on each sale. Operating expenses also increased across research and development, sales and marketing, and general and administrative functions, supporting technology investments and integration activities.
Net loss widened to approximately $1.48 million from about $1.06 million a year earlier, and cash, cash equivalents and restricted cash totaled roughly $910 thousand as of March 31, 2026. Management highlighted continued integration of Percentil and ShoeSize.Me and growth at Orgad and Naiz Fit as MySize builds an AI-driven, multi-channel fashion technology platform.
My Size, Inc. reported sharply higher revenue but deeper losses and mounting liquidity pressure for the three months ended March 31, 2026. Revenue rose to $2.4 million from $1.5 million, mainly from its fashion e-commerce platform and the addition of Percentil’s resale activity.
Gross profit more than doubled to $0.9 million, yet operating expenses increased faster, pushing operating loss to $1.4 million and net loss to $1.5 million, both wider than a year earlier. Cash, cash equivalents and restricted cash fell to $0.9 million from $2.6 million at year-end.
Management states there is substantial doubt about the company’s ability to continue as a going concern, expecting continued losses and negative cash flows. The company is relying on cost controls, product commercialization and additional financing, including its At The Market equity program, to fund operations.
MySize, Inc. files its annual report describing a fashion technology platform built around four units: Naiz Fit size-and-fit SaaS, Orgad Amazon overstock commerce, Percentil second-hand recommerce, and Ten Peacks apparel distribution in Israel. The company highlights acquisitions of Percentil’s production unit, ShoeSize.Me, and the formation of Ten Peacks to deepen its integrated data-driven fashion platform.
MySize reports heavy losses and an accumulated deficit, and its auditor raises substantial doubt about its ability to continue as a going concern. Management discloses it must raise additional capital to fund operations, while continuing to invest in AI sizing, recommerce infrastructure, and marketplace pricing technologies.
SIZE, INC. filed a Form 12b-25 notifying the SEC that its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 could not be timely filed due to delays in collecting and compiling certain required information. The company states it intends to file within the 15-day extension period provided by Rule 12b-25.